Suppr超能文献

在原代培养中,大鼠和人肝细胞将利非布罗(U-83860)生物转化为混合甘油酯代谢物。

Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.

作者信息

Sun E L, Feenstra K L, Bell F P, Sanders P E, Slatter J G, Ulrich R G

机构信息

Investigative Toxicology, Pharmacia and Upjohn, Inc., Kalamazoo, MI 49007, USA.

出版信息

Drug Metab Dispos. 1996 Feb;24(2):221-31.

PMID:8742235
Abstract

Lifibrol (U-83860), K12.148) is a lipid-lowering drug that has the potential to accumulate in the liver and induce hepatic peroxisome proliferation. To investigate the identity and potential human relevance of persistent lifibrol-related residues in rat liver, rat and human hepatocyte primary cultures were treated with 30 microM of [14C]lifibrol. After a steady uptake for 24 hr, cellular levels of radioactivity became stable for the next 24-48 hr. A nonradioactive lifibrol chase caused an efflux of intracellular radioactivity. Cellular autoradiography revealed the association of radioactivity with small lipid drops at 6 hr exposure and with large lipid drops at 24 hr exposure. HPLC analysis of media revealed that lifibrol acyl glucuronide and a t-butylcarboxylic acid metabolite (U-94613) were the major metabolites of rat and human hepatocytes, respectively. Using an HPLC method suitable for nonpolar metabolites, the analysis of rat and human cell extracts revealed a broad band of multiple, radioactive peaks that had a similar retention and UV spectrum to a synthetic standard of lifibrol cholesterol ester. Folch extracts of liver from rats treated with [14C]lifibrol or unlabeled lifibrol and [14C]acetate had a unique radioactive TLC band that had similar HPLC retention to hepatocyte residues. The group of nonpolar peaks from the hepatocytes was purified by HPLC. Conversion of the lifibrol sec-hydroxy group to a nicotinate ester afforded particle beam-electron impact mass spectra of the cholesterol ester standard and hepatocyte residues. The derivatized rat hepatocyte residue did not contain detectable lifibrol cholesterol ester (M+.816), but did contain molecular ion clusters corresponding to a mixed triglyceride of lifibrol and two fatty acids. Lifibrol-specific product ions of molecular ion clusters centered at M+.1021, 1047, and 1073 were observed at m/z 448, 430, and 310. The major lifibrol-containing triglycerides had a fatty acid composition of C16-C20 with 0-6 unsaturations.

摘要

利非布罗(U - 83860,K12.148)是一种降脂药物,有可能在肝脏中蓄积并诱导肝脏过氧化物酶体增殖。为了研究大鼠肝脏中与利非布罗相关的持久性残留物的特性及其与人类的潜在相关性,用30微摩尔的[14C]利非布罗处理大鼠和人类肝细胞原代培养物。在稳定摄取24小时后,放射性的细胞水平在接下来的24 - 48小时内保持稳定。用非放射性利非布罗进行追踪导致细胞内放射性流出。细胞放射自显影显示,在6小时曝光时放射性与小脂滴相关,在24小时曝光时与大脂滴相关。对培养基的HPLC分析表明,利非布罗酰基葡萄糖醛酸和叔丁基羧酸代谢物(U - 94613)分别是大鼠和人类肝细胞的主要代谢物。使用适用于非极性代谢物的HPLC方法,对大鼠和人类细胞提取物的分析显示出一条宽带状的多个放射性峰,其保留时间和紫外光谱与利非布罗胆固醇酯的合成标准品相似。用[14C]利非布罗或未标记的利非布罗及[14C]乙酸处理的大鼠肝脏的福尔克提取物有一条独特的放射性TLC带,其HPLC保留时间与肝细胞残留物相似。通过HPLC对肝细胞中的非极性峰组进行了纯化。将利非布罗仲羟基转化为烟酸酯后,得到了胆固醇酯标准品和肝细胞残留物的粒子束 - 电子轰击质谱。衍生化的大鼠肝细胞残留物中未检测到利非布罗胆固醇酯(M +.816),但确实含有对应于利非布罗与两种脂肪酸的混合甘油三酯的分子离子簇。在m/z 448、430和310处观察到以M +.1021、1047和1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验